Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.
The note said that 10 vials of a Valeant made drug that cost her $180 back in the 1980s, now cost her $14,729.99. Valeant, a $40 billion firm, has been under intense government scrutiny for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback